Francesco Pignatti

6PUBLICATIONS
33CO-AUTHORS
Epidemiological methodsEconometric and statistical methodsAnimal physiology - cellHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser

|May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-Offs.

Francesco Pignatti, Filip Josephson, Pierre Demolis

|May 08, 2025
Novel PET RANO BM 1.0 criteria: Regulatory perspectives on new endpoint definitions in brain metastases.

Francesco Pignatti, Ralf Herold, Pierre Demolis

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Aug 04, 2023
Queries Raised During Oncology Business Pipeline Meetings at the European Medicines Agency: A 5-Year Retrospective Analysis.

C Mircea S Tesileanu, Francesco Pignatti, Enrico Tognana

|Dec 07, 2021
The value of anticancer drugs - a regulatory view.

Francesco Pignatti, Ulla Wilking, Douwe Postmus

Pageof 1